HIV infections may rise without U.S. support, says UNAIDS leader.

UNAIDS leader warns of potential consequences after Trump halts foreign aid for 90 days.

February 10th 2025.

HIV infections may rise without U.S. support, says UNAIDS leader.
The head of the UNAIDS agency, Winnie Byanyima, is expressing deep concern over the potential increase of new HIV infections by 2029. This bleak prediction is a direct result of the recent decision by President Donald Trump to freeze all foreign assistance for 90 days. Byanyima, speaking from Uganda, explained that without American support, the world could see a surge in the disease that would cost countless lives. However, she made it clear that it is not her place to criticize any government's policies.

As the leading organization for collecting and analyzing HIV and AIDS data, UNAIDS has been instrumental in the fight against this deadly virus. Byanyima reported that there has been a significant decrease in HIV infections over the past two decades, with a 60% decline since the virus peaked in 1995. However, without the support of the United States, Byanyima fears that the progress made could be reversed. She predicts that there could be close to 9 million new infections, resulting in nearly 7 million deaths and an additional 3 million children infected. Without proper mitigation efforts, there is also a risk of new strains of the virus emerging.

Byanyima expressed her frustration with Trump's decision, stating that it has caused panic, fear, and confusion in countries that are already heavily impacted by HIV and AIDS. In countries like Kenya and Ethiopia, thousands of HIV workers have already lost their jobs, making it difficult to track and combat the epidemic. This is particularly alarming since the U.S. provided 90% of UNAIDS' funding, with a significant portion invested in countries like Uganda, Mozambique, and Tanzania.

What makes this situation even more frustrating for Byanyima is the fact that the U.S. foreign assistance only accounts for less than 1% of its overall budget. She pointed out that the lifesaving medication, lenacapavir, was developed by an American company called Gilead, providing an economic opportunity. By halting funding, the U.S. is not only putting lives at risk but also hindering its own economic interests.

As of now, there has been no significant aid from other countries to fill the gap left by the U.S. However, Byanyima remains hopeful that this will change. She emphasized that people's lives are at stake and that without proper funding, lifesaving tools will be taken away from those who need them. Byanyima also highlighted the importance of humanity and urged other countries to step in and assist in any way they can.

In the midst of this global crisis, the HIV/AIDS community has also suffered a significant loss with the passing of A. Cornelius Baker. His tireless advocacy efforts and dedication to the cause will be deeply missed. It is a reminder of the urgent need for continued support and funding to fight against this deadly virus.

[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]

 0
 0